Prehistoric bacteria may act as "vectors" to deliver cancer drugs
Added: Friday 9 September 2011
UK and Dutch scientists have succeeded in making a prehistoric bacterium activate cancer drugs. Clostridium sporogenes evolved on the planet before it had an oxygen-rich atmosphere, which means it thrives in low oxygen conditions such as soil. Professor Nigel Minton, the University of Nottingham scientist who led the research, said: "When Clostridia spores are injected into a cancer patient, they will only grow in oxygen-depleted environments, i.e. the centre of solid tumours. We can exploit this specificity to kill tumour cells but leave healthy tissue unscathed."
In order to be able to see the content from the www.medscape.com pages, please create first a free account at following link: